China , which is one of the largest pharmaceutical markets in the world, is also a leading producer of pharmaceutical ingredients. The market is currently expanding at a double-digit rate, which is being driven by improvements in intellectual property protection and increased government support for R&D, alongside a gentrifying population, expanding medical coverage and growing exports. It's dynamic economy is forecast to reach a staggering $154 billion by 2018.
Every year, more and more multinational companies are establishing their long-term presence in China market, due to highly skilled & low-cost labour, progressive government reforms, modernisation of domestic manufacturing sector, increasing research & development capacities.
China has increasingly become a focal point of the pharmaceutical industry and is one of the largest market in the world. Fuelled by increasing health-care demands within its own borders as well as by international companies seeking manufacturing facilities, China's hunger for foreign partnerships and pharmaceutical ingredients presents a great opportunity for international and domestic suppliers and buyers.
Since healthcare is one of the three greatest economic burdens in China, along with housing and education, reform of the healthcare system has been a major priority of the Chinese government to make it more affordable.
According industry cognoscenti,China’s pharmaceutical industry will see golden days in upcoming years as many MNC’s are eager to invest money in china and also due to increased involvement of government. New amendments in patent law will decrease patent infringements in the future and Chinese government is expected to make progress on the enforcement of existing patent law.
CPhI China, is returning to the Shanghai New International Expo Center from June 24-26 ,2015 for the 15th consecutive year with an increased scale, more informative exhibitions and regional networking opportunities and a greater range of content services than it has ever offered before. Furthermore, the 2015 event has a strong focus on R&D with LABWorld, BioPharma, ICSE, Natural Extracts & EP Clean Tech.
According to Chris Kilbee, Group Director of Pharma at UBM, “CPhI China and its 15th year has grown considerably over the years and now is the premier event for pharma ingredients, machinery, packaging, and many other associated verticals to bring the pharma world together. So we are really looking forward to a very special CPhI China in 2015. ”
Over 2,800 exhibitors and 30,000 attendees from more than 100 countries will be participating in CPhI & P-MEC China. This event has expanded its show floor this year to 140,000 square metres, allowing for even more networking and learning opportunities.
An extensive programme of 80 plus conferences, summits and seminars will feature across the three-day event, including the 6th China World CEO Summit; 2015 Pharmaceutical R&D innovation and Outsourcing Management Conversation and 2nd BioPh China Summit 2015, to name just a few.
This year, the event celebrates a decade in partnership with P-MEC China and will co-locate with ICSE, BioPh, Innopack, LABWorld, Fi Asia China and Hi China. This eight-shows-in-one event brings China’s entire supply chain together in one location, with global suppliers of raw materials, ingredients, packaging solutions, machinery, manufacturing and more present.
In addition to ingredients, the show also features a Natural Extracts, Logistics, Finished Formulation, and Environmental Projections & Clean zones.
While P-MEC China covers machinery and equipment; ICSE China covers companies providing outsourcing services in custom synthesis and clinical trials; BioPh China is a dedicated platform for biopharmaceuticals and InnoPack, focuses on bringing global packaging solutions to the Chinese pharma companies.LABWorld China will be focusing on innovation and new developments, providing a forum for increased education and networking for businesses in the laboratory, analytical and biotech equipment sector.
Two featured events namely Natural Extracts and EP Clean Tech exhibits 400 suppliers of natural extracts and showcases the latest products and technologies of the industry and clean technology & environmental protection designed to meet the high standards required by pharmaceutical manufacturing, respectively.
P-MEC China as the leading event, showcases pharma machinery & equipment and offers an exclusive trading platform for accessing the Chinese pharma market.
As China's pharmaceutical market continues to grow and develop, local companies are keen to purchase high-quality pharmaceutical machinery and equipment that can help them to meet tough challenges such as new GMP implementation, changing import/export situation and the Medical Reform. P-MEC China is attracting more and more visitors each year. They include specialists from general management, marketing & sales, Purchasing, production, quality control, engineering and R&D. On average, nearly 70 per cent of all visitors have real purchasing power.
ICSE China is dedicated to contract services by offering outsourcing solutions such as clinical trials, biotechnology and contract research. Held alongside CPhI China, ICSE attracts international exhibitors who are keen to capitalize on the benefits of doing business in China. Besides contract manufacturing and contract research, other main services provided are packaging, clinical trials, laboratory services, drug discovery and marketing services. For functions within the biotechnology or pharmaceutical industry, ICSE shows how an organisation can benefit from outsourcing to China and enable them to arrange it.
ICSE China is the only specific theme exhibition held for the CRO&CMO industry. Being held concurrently with LABWorld China and BioPh China, it offers all pharmaceutical companies a one stop CRO&CMO outsourcing procurement platform and an excellent bridge for communication with industry peers and for exchanging latest industry information.
LabWorld China features laboratory, analytical & biotech companies with a focus on innovation and new developments. LABWorld China is an effective networking event for any business or individual in the laboratory, analytical & biotech equipment sector. With a focus on innovation and new developments, LABWorld China responds to the rapid growth in the number of participants focused on high technology areas such as instrumental analysis, testing technologies, materials testing, quality control and laboratory equipment.
InnoPack China is a dedicated to pharma packaging bringing global packaging solution providers and their latest innovations to the Chinese pharmaceutical community. Pharmaceutical manufacturers in China are increasingly seeking more sophisticated and reliable packaging solutions to deal with the rapid-changing demand of the Chinese and global pharma markets. Co-located with three specialised events on ingredients, outsourcing, machinery and equipment, Innopack China brings together quality suppliers and focused buyers. It is one of the best opportunity to market or source pharma packaging products and services in China's pharmaceutical market.
BioPh focuses on biotechnology and related fields offering and ideal platform for biopharma companies, drug discovery organizations, pharma manufacturers and scientific research institutions to create new partnerships and discuss latest trends. All companies and organizations dealing with the research and development of new treatment methods made through biotechnological processes or which are derived from or use live organisms will benefit from the mix of exhibition and seminars at BioPh.
Thanks to the influence of the traditional Chinese medicine culture, the Chinese plant extract industry has unique developing advantages. China is now regarded as an important international natural extract ingredient supplier. They have achieved this status by combining resource utilization with competitive pricing. Of all the natural extract categories, plant extracts and medicinal herbs have become the most well known. This is due to a mixture of China's access to vast territories with abundant plant resources, and their centuries of traditional Chinese medicine development. Currently there are over 2,000 companies manufacture and trade of plant extracts in the country.
Environmental Protection & Clean Tech Area focuses on clean technology and environmental protection designed to meet the high standards required by pharmaceutical manufacturing.
The new event FPLogistics 2015, international food & pharma industry, logistics equipment & service exhibition, gathers exhibitors and providers of logistics equipment, technologies and services on food and pharmaceutical industries. It is the leading industry platform in Asia for supply chain and logistics decision makers, logistics service suppliers and all other industry stakeholders to meet, network and discuss latest industry trends, partnership models and new technologies in Asia.
In 2015, CPhI, ICSE & BioPh China teams up again to roll out the "CPhI Buyers Sourcing Event". The event is a purchase matching service, which brings renowned overseas buyers to meet suppliers from China, aiming to help suppliers establish relationship with international buyers, understand the international market and capture effective business opportunities. As one of the special events held annually on-site at CPhI, ICSE & BioPh China, Buyers Sourcing Event effectively draws buyers closer to suppliers through one-to-one and face-to-face meetings and drives both parties to close deals. And its mode of cutting cost by reducing intermediate links is recognized by more and more domestic and overseas buyers.
CPhI China along with its co-located events will be coordinating conferences which offers numerous opportunities to meet with influential speakers, senior executives and network on C-level. The conferences will be held in three days from June 23 to 25.
CPhI & P-MEC China will be having an increased Indian participation compared to last year, with even more Indian exhibitors looking to grow their business contacts and opportunities within the China pharma market. In total, 42 Indian companies will be exhibiting including prominent industry businesses Alchem International Ltd, Pharmexcil, Granules Indian Ltd and Hetero Labs Ltd.
CPhI & P-MEC China 2014 was a great success, with over 2,540 companies exhibiting and more than 30,000 attendees over the three-day event. Of the exhibitors from the 2014 event, more than 1,500 enterprises applied for the 2015 exhibition - a rebooking rate of 70 per cent. This highlighted the attractiveness and recognition of the CPhI brand as the regional pharma hub.